BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 7.82 +0.07 (0.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.75 | 52 Week High | $10.98 | |||
| Open | $7.78 | 52 Week Low | $1.63 | |||
| Day High | $7.88 | P/E | N/A | |||
| Day Low | $7.66 | EPS | $-0.68 | |||
| Volume | 365,260 | |||||
